Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New indication approved for AmBisome in the U.K.

Aug. 24, 1998

Hoechst describes novel antibiotic feglymycin

Aug. 21, 1998

Glaxo Wellcome synthesizes improved carbapenem antibacterials

Aug. 20, 1998

U.S. patent issued for MediChem Research's antiviral biflavanoids

Aug. 19, 1998

Medivir synthesizes esters of antiviral nucleosides with improved bioavailability

Aug. 19, 1998

Antifungal agents disclosed by Sankyo in patent literature

Aug. 19, 1998

Potent anti-HSV-1 activity demonstrated with BILD-1633-SE in vivo

Aug. 18, 1998

Synagis submitted for review by EMEA; product now available in U.S.

Aug. 17, 1998

Isolation and antibiotic activity of spiroximicin reported

Aug. 17, 1998

Pharmacokinetics of SPK-843, a promising new antifungal agent

Aug. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.